Page last updated: 2024-08-21

medroxyprogesterone and Fibrocartilaginous Dysplasia of Bone

medroxyprogesterone has been researched along with Fibrocartilaginous Dysplasia of Bone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hauffa, BP; Havers, W; Stolecke, H1
Huffman, JW1

Other Studies

2 other study(ies) available for medroxyprogesterone and Fibrocartilaginous Dysplasia of Bone

ArticleYear
Short-term effects of testolactone compared to other treatment modalities on longitudinal growth and ovarian activity in a girl with McCune-Albright syndrome.
    Helvetica paediatrica acta, 1987, Volume: 42, Issue:5-6

    Topics: Androgen Antagonists; Body Height; Bone Development; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Female; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Follow-Up Studies; Humans; Infant; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Cysts; Ovarian Function Tests; Spironolactone; Testolactone

1987
Gynecologic endocrine disorders in childhood and adolescence.
    Clinical obstetrics and gynecology, 1973, Volume: 16, Issue:4

    Topics: Adolescent; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Cerebral Ventricle Neoplasms; Child; Child, Preschool; Cortisone; Endocrine System Diseases; Female; Fibrous Dysplasia of Bone; Granulosa Cell Tumor; Humans; Infant, Newborn; Medroxyprogesterone; Menopause; Menstruation Disturbances; Ovarian Cysts; Ovarian Neoplasms; Pigmentation Disorders; Progesterone; Puberty, Precocious; Sertoli-Leydig Cell Tumor; Sex Chromosome Aberrations; Turner Syndrome; Vaginal Smears; Virilism

1973